These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9603407)

  • 1. Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation.
    Chiusolo P; Salutari P; Sica S; Scirpa P; Laurenti L; Piccirillo N; Leone G
    Bone Marrow Transplant; 1998 Apr; 21(8):821-3. PubMed ID: 9603407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases.
    Somali M; Mpatakoias V; Avramides A; Sakellari I; Kaloyannidis P; Smias C; Anagnostopoulos A; Kourtis A; Rousso D; Panidis D; Vagenakis A
    Gynecol Endocrinol; 2005 Jul; 21(1):18-26. PubMed ID: 16048797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and endocrine effects of leuprorelin acetate in pre- and postmenopausal patients with advanced breast cancer.
    Dowsett M; Jacobs S; Aherne J; Smith IE
    Clin Ther; 1992; 14 Suppl A():97-103. PubMed ID: 1606596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
    Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
    Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.
    Schmid P; Untch M; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Lehmann U; Maubach L; Meurer J; Wallwiener D; Possinger K
    J Clin Oncol; 2007 Jun; 25(18):2509-15. PubMed ID: 17577027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal replacement therapy after stem cell transplantation.
    Piccioni P; Scirpa P; D'Emilio I; Sora F; Scarciglia M; Laurenti L; De Matteis S; Sica S; Leone G; Chiusolo P
    Maturitas; 2004 Dec; 49(4):327-33. PubMed ID: 15531129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause.
    Imai A; Sugiyama M; Furui T; Tamaya T
    J Obstet Gynaecol; 2003 Sep; 23(5):518-20. PubMed ID: 12963511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary endocrine therapy as pre- and perimenopausal metastatic breast carcinoma with leuprorelin acetate depot. German Leuprorelin Study Group].
    Untch M
    Zentralbl Gynakol; 1998; 120(6):284-92. PubMed ID: 9659699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate.
    Laufer MR; Townsend NL; Parsons KE; Brody KA; Diller LR; Emans SJ; Guinan EC
    J Reprod Med; 1997 Sep; 42(9):537-41. PubMed ID: 9336747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant.
    Devine SM; Sanborn R; Jessop E; Stock W; Huml M; Peace D; Wickrema A; Yassine M; Amin K; Thomason D; Chen YH; Devine H; Maningo M; van Besien K
    Bone Marrow Transplant; 2001 Sep; 28(6):557-62. PubMed ID: 11607768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
    Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menstrual cycle and sex hormone profile in perimenopausal women after liver transplantation.
    Jabiry-Zienjewicz Z; Kaminski P; Bobrowska K; Pietrzak B; Wielgos M; Zieniewicz K; Krawczyk M
    Transplant Proc; 2006 Nov; 38(9):2909-12. PubMed ID: 17112861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and Effectiveness of Gonadotropin-Releasing Hormone Agonists for Prophylactic Menstrual Suppression in Postmenarchal Women Who Undergo Hematopoietic Cell Transplantation.
    Poorvu PD; Barton SE; Duncan CN; London WB; Laufer MR; Lehmann LE; Marcus KJ
    J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):265-8. PubMed ID: 26506031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
    Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary investigation of the nasal delivery of liposomal leuprorelin acetate for contraception in rats.
    Shahiwala A; Misra A
    J Pharm Pharmacol; 2006 Jan; 58(1):19-26. PubMed ID: 16393460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian response and pregnancy outcome related to midfollicular LH levels in down-regulated women undergoing assisted reproduction.
    Ferrari B; Barusi L; Lanna M; Coppola F
    J Reprod Med; 2004 Mar; 49(3):148-52. PubMed ID: 15098883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
    Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
    Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.